![3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide structure](/static/products/6879/6879-09-0.webp)
3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide
TL;DR: 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide (CAS 6879-09-0) is a chemical compound with molecular formula C25H20ClN3O4 and molecular weight 461.11 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide
Also Known As: 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide, 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxo-pyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide, 3-{[4-chloro-1-(2-methylphenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]amino}-N-(4-methoxyphenyl)benzamide
| Molecular Formula | C25H20ClN3O4 |
|---|---|
| Molecular Weight | 461.11 g/mol |
| LogP | 4.69162 |
| Topological Polar Surface Area | 87.74 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Exact Mass | 461.11423 |
| Heavy Atoms | 33 |
| Complexity | 1284.8193 |
Chemical Identifiers
| CAS Number | 6879-09-0 |
|---|---|
| SMILES | CC1=CC=CC=C1N2C(=O)C(=C(C2=O)Cl)NC3=CC=CC(=C3)C(=O)NC4=CC=C(C=C4)OC |
Product Overview
3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide (CAS 6879-09-0), with molecular formula C25H20ClN3O4 and molecular weight 461.11 g/mol. IUPAC: 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide.
Chemical Property Profile of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide
Property Insights of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide
The XLogP value of 4.69162 indicates that 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 87.74 Ų falls within the moderate polarity range, balancing permeability and solubility for 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide. Following Lipinski's Rule of Five, 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide?
The CAS number of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide is 6879-09-0.
What is the molecular formula of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide?
The molecular formula of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide is C25H20ClN3O4.
What is the molecular weight of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide?
The molecular weight of 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide is 461.11 g/mol.
Where can I buy 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide?
You can request a quote for 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide?
Yes, KEHONG BIO provides custom synthesis services for 3-[[4-chloro-1-(2-methylphenyl)-2,5-dioxopyrrol-3-yl]amino]-N-(4-methoxyphenyl)benzamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.